Vaccinations Related Content

Gino Martini, RPS Chief Scientist and the Science and Research Team at the Royal Pharmaceutical Society reflect on the role of pharmacy during COVID-19 in delivering accessible, safe and effective care for all.

European Public Health Association Executive Director, Dineke Zeegers Paget examines COVID-19 as a societal issue, not just a pandemic and argues that solidarity here is needed the most.

While the US and UK sealed their BioNTech and Pfizer vaccine deals within 24 hours of the new results, the European Commission took 3 days longer to secure their larger order of 300 million doses.

Yesterday, at 6:45am in the US, the Pfizer vaccine was revealed to be over 90% effective - so when will the successful drug be available for the UK to use?

Created without US Government funding, the BioNTech and Pfizer vaccine is revealed to be over 90% effective against COVID-19.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group considers how the standard of healthcare for patients with diabetes is impacted by COVID-19.

Over 12 US Immigration and Customs Enforcement (ICE) detention centres had multiple outbreaks of infectious disease - due to withholding vaccines for adult and child migrants.

While AstraZeneca and Oxford University continue to work on a UK COVID-19 vaccine, what about the rest of the world?

A study published in Clinical Infectious Diseases found that hydroxychloroquine did not work to protect healthcare professionals from COVID-19.

Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.

Open Access Government explores the European Commission’s Department of Health and Food Safety’s response to the COVID-19 crisis and charts their next steps towards a vaccine for every European citizen.

A new study has revealed that COVID-19 antibodies fade after only a month, which could be a devastating blow in the global race to find a vaccine.

Russia is the first country to announce the approval of a COVID-19 vaccine, without completing clinical trials.

Professor Martin Michaelis and Dr Mark Wass, School of Biosciences at University of Kent, explain the long and infamous history of human infection trials.

Scientists from the University of Oxford, joint with AstraZeneca, are hopeful that their vaccine, to protect against Covid-19, could be available as early as September.

The Immunisation For All Ages group discusses the importance of protecting vaccine budgets and immunisation infrastructure, even amidst COVID-19.

President von der Leyen, Council President Charles Michel and Prime Minister of Japan Shinzō Abe, discussed the global response to the COVID-19 pandemic.

Here we summarise a discussion with experts on the EU response to COVID-19 and the role of Horizon Europe in this pandemic.

Researchers have found that people who use social media for news are more likely to experience vaccine misinformation.

The Government has today pledged £20 million to develop a new coronavirus vaccine following concerns over the ongoing outbreak in China.